The DOI matches its Crossref record.
FLUVOXAMINE, A SPECIFIC 5‐HYDROXYTRYPTAMINE UPTAKE INHIBITOR
Open accessAbstract
1 On the basis of both in vitro and in vivo experiments fluvoxamine has been characterized as a potential anti‐depressant drug with almost exclusively 5‐hydroxytryptamine (5‐HT) uptake inhibiting properties. 2 Fluvoxamine is effective in inhibiting 5‐HT uptake by blood platelets and brain synaptosomes. Due to inhibition of the membrane pump the compound prevents 5‐HT depletion by the tyramine‐derivatives H 75/12 and H 77/77. As a result of the interference with the neuronal re‐uptake mechanism for 5‐HT, fluvoxamine produces a decreased 5‐HT turnover in the brain. Effects of 5‐hydroxytryptophan (5‐HTP) are potentiated in mice and in combination with pargyline, fluvoxamine induces 5‐HT‐like behavioural effects. 3 In contrast to tricyclic antidepressants, noradrenaline uptake processes are either unaffected or only slightly inhibited by fluvoxamine. The noradrenaline depleting effects of tyramine derivatives are not influenced by fluvoxamine. Reserpine effects, such as ptosis are affected only at very high doses of the test compound. The antagonism by fluvoxamine of the reserpine‐induced lowering of the pentamethylenetetrazole convulsive threshold can be regarded as due to an effect upon 5‐HT uptake. In contrast to the effects of desmethylimipramine and imipramine, no stimulatory effects are found in rats when rapidly acting reserpine‐like compounds are given following a dose of fluvoxamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Benfield, P., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632040-00002 · Cited by 494
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., et al. (2021) · Neurology International · doi:10.3390/neurolint13030038 · Cited by 440
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
Bel, N., & Artigas, F. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90292-c · Cited by 269
Serotonin: A never-ending story
Olivier, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.031 · Cited by 253
Metadata
- Authors
- CLAASSEN, V., DAVIES, J. E., HERTTING, G., & PLACHETA, P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1977-08
- Volume
- 60
- Issue
- 4
- Pages
- 505-516
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2028094236
- Cited by
- 178
- References
- 0
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FLUVOXAMINE, A SPECIFIC 5‐HYDROXYTRYPTAMINE UPTAKE INHIBITOR. https://app.cochat.ai/papers/10.1111/j.1476-5381.1977.tb07528.x
- The paper
- CLAASSEN, V., DAVIES, J. E., HERTTING, G., & PLACHETA, P. (1977). FLUVOXAMINE, A SPECIFIC 5‐HYDROXYTRYPTAMINE UPTAKE INHIBITOR. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1977.tb07528.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.